Can cutaneous leishmaniasis provoke a resurgence of kala-azar in the Indian subcontinent?
- PMID: 40012028
- PMCID: PMC11866896
- DOI: 10.1186/s12879-025-10664-5
Can cutaneous leishmaniasis provoke a resurgence of kala-azar in the Indian subcontinent?
Abstract
Background: The ongoing kala-azar elimination program in Nepal is based on the assumption of anthroponotic transmission of the protozoan parasite Leishmania donovani. This parasite species was recently also found in lesions of cutaneous leishmaniasis (CL) cases, which are increasingly reported mainly from western Nepal. The question whether or not CL causing L. donovani can also contribute to VL is a crucial one to answer if the success of the VL elimination initiative in the Indian subcontinent is to be sustained, though evidence on sub-species level genomic differences between CL and VL causing L. donovani is currently lacking. This study aims to provide a genomic comparison of L. donovani parasites currently causing CL in Nepal with previously described L. donovani isolates.
Methods: A case series study was carried out in sentinel dermatological sites in Western Nepal. Skin punch biopsies were collected from clinically suspected CL lesions. Molecular tests based on the ribosomal RNA gene array were used to detect and characterize the Leishmania parasites.
Results: Leishmania parasites detected in 26 cutaneous leishmaniasis patients were identified as L. donovani. Importantly, their analyzed DNA sequences were identical, and shared with previously documented sequences from both cutaneous and visceral disease-causing parasites in Nepal, India and Bhutan.
Conclusions: Our study suggests that CL and VL are caused by similar if not identical L. donovani parasite strains, though additional sequencing is required to corroborate this finding. If confirmed, cutaneous lesions could act as a kala-azar parasite reservoir, which would have important implications for the kala-azar elimination program.
Keywords: Leishmania donovani; Cutaneous leishmaniasis; Genomic surveillance; Kala-azar elimination initiative; Nepal; Parasite characterization; Visceral leishmaniasis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was conducted according to the guidelines of the Declaration of Helsinki. Ethical approval for this study was obtained from the relevant committees in Nepal (Institutional Review Committee of BPKIHS IRC/2450/023, Dharan, and from the National Health Research Council, Kathmandu 45/2023P) and Belgium ((Institutional Review Board of the Institute of Tropical Medicine (ref: 1637/22, 25 November 2022), Ethics Committee of the University of Antwerp Hospital in Antwerp (Project ID: 5161, 6 March 2023)). Written informed consent was obtained from all participants involved in the study. The consent of a parent or legal guardian was obtained from any participant who was under the age of 18. In the event of illiterate participants/legal representative, a thumbprint and the signature of a neutral witness were used. All data were pseudonymized with the use of a sample ID. Consent for publication: Not applicable. Clinical trial number: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- World Health Organization. Regional Strategic Framework for Elimination of kala-azar from the South-East Asia Region (2005–2015). New Delhi: Regional Office for South-East Asia. 2005. Available from: https://www.who.int/publications-detail-redirect/sea-cd-239
-
- Global Health Observatory. Number of cases of visceral leishmaniasis reported: World Health Organization. 2024. Available online: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/numbe.... Accessed on 24 May 2024.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
